M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 3.55 USD 0.28%
Market Cap: 373.8m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Stock-Based Compensation Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Stock-Based Compensation
$14m
CAGR 3-Years
78%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Stock-Based Compensation
$19.1m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MaxCyte Inc's Stock-Based Compensation?
Stock-Based Compensation
14m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Stock-Based Compensation amounts to 14m USD.

What is MaxCyte Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
60%

Over the last year, the Stock-Based Compensation growth was 19%. The average annual Stock-Based Compensation growth rates for MaxCyte Inc have been 78% over the past three years , 60% over the past five years .

Back to Top